Vincent O. Dezentje - Publications

Local ablative treatment and continuation of systemic therapy for oligoprogressive metastatic breast cancer: a retrospective cohort study.

Journal: Cancer treatment and research communications

Published: March 04, 2026

Tailoring axillary treatment in patients with isolated locoregional recurrent breast cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 15, 2025

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.

Journal: European urology oncology

Published: April 30, 2025

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

Journal: Targeted oncology

Published: May 20, 2024

The efficacy of screening with FDG-PET/CT for distant metastases in breast cancer patients scheduled for neoadjuvant systemic therapy.

Journal: Breast cancer research and treatment

Published: April 03, 2024

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD.

Journal: Genome medicine

Published: March 29, 2024

Treatment sequences and survival outcomes in advanced HR + HER2- breast cancer patients: a real-world cohort.

Journal: Breast cancer research and treatment

Published: March 27, 2024

A Genome-Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early-Stage Breast Cancer Patients.

Journal: Clinical pharmacology and therapeutics

Published: November 06, 2023

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy.

Journal: Clinical genitourinary cancer

Published: October 31, 2023

Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone Acetate.

Journal: Pharmaceutical research

Published: July 21, 2023

Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer.

Journal: Cancers

Published: December 23, 2022

Exposure-Response Analyses of Olaparib in Real-Life Patients with Ovarian Cancer.

Journal: Pharmaceutical research

Published: December 05, 2022